When President Joe Biden signed the CHIPS and Science Act into law in August it was one of the few pieces of legislation embraced across the aisle in a hyper-partisan climate. CHIPS aimed, in part, to address the dire shortage of semiconductors – computer chips essential to running everything from household appliances to lifesaving medical devices – that US industry faced.
Support for the legislation only increased during the pandemic when supply chain shortages highlighted the risk of relying on overseas...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?